Background: Benign breast diseases encompass a variety of non-cancerous conditions that affect the breast tissue, causing significant discomfort and anxiety among patients. This study aims to evaluate the efficacy of the triple assessment approach—clinical examination, fine needle aspiration cytology (FNAC), and imaging studies—in diagnosing benign breast diseases and to analyze the correlation between these diagnostic methods and final histopathological findings. Methods: A total of 150 female patients presenting with breast symptoms were included. Clinical examination, FNAC, and imaging (ultrasound and mammography) were performed. Histopathological examination was conducted for cases with uncertain or suspicious FNAC results. Data were analyzed using descriptive statistics and chi-square tests to evaluate diagnostic accuracy. Results: The study population had a mean age of 34.5 years, with the majority (60%) in the 21–40-year age group. FNAC identified fibroadenoma in 50% of cases, fibrocystic changes in 25%, benign cysts in 10%, and inflammatory conditions in 15%. Imaging findings were consistent with FNAC results in most cases. Histopathology confirmed benign conditions in all examined cases. FNAC demonstrated high sensitivity (92%) and specificity (85%), with a statistically significant correlation to histopathological findings (p < 0.05). Conclusion: The triple assessment approach is effective in diagnosing benign breast diseases, with FNAC showing high diagnostic accuracy. Imaging studies further enhance diagnostic precision. This integrated method ensures accurate diagnosis and appropriate management of benign breast conditions, improving patient care and outcomes. Recommendations: Routine implementation of the triple assessment approach in clinical practice is recommended to ensure accurate diagnosis and management of benign breast diseases. Further research on the long-term outcomes of patients diagnosed with benign breast conditions using this approach is suggested to refine diagnostic protocols.